Mitegen Awarded $250K NIH STTR Phase II Grant
Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a phase II STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of improved crystallization plates.
Ithaca, NY, June 27, 2011 --(PR.com)-- The funding to begin July 1, 2011 and continue through until June 30, 2013 will provide for tooling and manpower to further proprietary ultra-transparent drop-pinning plate technologies that have been developed at Cornell University and licensed to Mitegen. First generation prototypes were developed in 2010 for initial performance studies, and yielded excellent results with X-ray scatter significantly lower than currently available plates.
“This patented technology promises to address many deficiencies of existing crystallization plates, and allow in-situ X-ray inspection of crystallization experiment outcomes,” says Robert Thorne, Chairman and CTO of Mitegen. “Our goal is to deliver a low-cost plate in a standard format so that it can be rapidly adopted.”
30% of the award will be filtered back to Cornell for continued fundamental research on drop pinning and exploration of applications to other areas of biotechnology. The remainder of the funds will be used to develop second generation prototypes, tooling, and supply chains. Test product will be available to Beta partners later in 2011 and commercial production of the first products will commence thereafter.
“Mitegen is proud to continue its tradition of innovation and advancement in tools for small molecule handling and crystallography. Awards such as this are fundamental to the development of new products and the growth of emerging businesses,” according to Robert Newman, CEO of Mitegen. “We are grateful for the continued partnership of universities such as Cornell and funding from NIH to help develop the science behind future innovations that will lead to more effective products for research scientists worldwide.”
About Mitegen
Mitegen designs, manufactures and distributes products for crystallization, crystallography and X-ray diffraction of proteins, viruses and small molecule/inorganic compounds, and for manipulation and measurement of small samples in cell biology, histology, clinical diagnostics, entomology, archaeology, art restoration and geology. Our customers include academic, medical, pharmaceutical, government and industrial laboratories in more than 40 countries.
Founded in 2004, Mitegen is based in Ithaca, NY. More information can be found at www.mitegen.com.
###
“This patented technology promises to address many deficiencies of existing crystallization plates, and allow in-situ X-ray inspection of crystallization experiment outcomes,” says Robert Thorne, Chairman and CTO of Mitegen. “Our goal is to deliver a low-cost plate in a standard format so that it can be rapidly adopted.”
30% of the award will be filtered back to Cornell for continued fundamental research on drop pinning and exploration of applications to other areas of biotechnology. The remainder of the funds will be used to develop second generation prototypes, tooling, and supply chains. Test product will be available to Beta partners later in 2011 and commercial production of the first products will commence thereafter.
“Mitegen is proud to continue its tradition of innovation and advancement in tools for small molecule handling and crystallography. Awards such as this are fundamental to the development of new products and the growth of emerging businesses,” according to Robert Newman, CEO of Mitegen. “We are grateful for the continued partnership of universities such as Cornell and funding from NIH to help develop the science behind future innovations that will lead to more effective products for research scientists worldwide.”
About Mitegen
Mitegen designs, manufactures and distributes products for crystallization, crystallography and X-ray diffraction of proteins, viruses and small molecule/inorganic compounds, and for manipulation and measurement of small samples in cell biology, histology, clinical diagnostics, entomology, archaeology, art restoration and geology. Our customers include academic, medical, pharmaceutical, government and industrial laboratories in more than 40 countries.
Founded in 2004, Mitegen is based in Ithaca, NY. More information can be found at www.mitegen.com.
###
Contact
Mitegen, LLC
Robert Newman
877-648-3436
www.mitegen.com
Robert Newman
877-648-3436
www.mitegen.com
Contact
Categories